Search

Coloplast A-S (Class B)

Închisă

564.6 0.57

Rezumat

Modificarea prețului

24h

Curent

Minim

558.6

Maxim

565.8

Indicatori cheie

By Trading Economics

Venit

70M

875M

Vânzări

2M

7B

P/E

Medie Sector

34.472

87.826

EPS

3.88

Randament dividend

4.24

Marjă de profit

12.572

Angajați

16,744

EBITDA

2B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.24%

2.26%

Următoarele câștiguri

6 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

2.5B

125B

Deschiderea anterioară

564.03

Închiderea anterioară

564.6

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 ian. 2026, 23:11 UTC

Câștiguri

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ian. 2026, 22:55 UTC

Principalele dinamici ale pieței

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ian. 2026, 21:39 UTC

Principalele dinamici ale pieței

Raytheon Down Following Trump Post Criticizing Company

7 ian. 2026, 20:13 UTC

Principalele dinamici ale pieței

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ian. 2026, 20:03 UTC

Principalele dinamici ale pieței

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ian. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 ian. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ian. 2026, 23:42 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ian. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ian. 2026, 23:29 UTC

Achiziții, Fuziuni, Preluări

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ian. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ian. 2026, 22:46 UTC

Câștiguri

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ian. 2026, 22:45 UTC

Câștiguri

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ian. 2026, 22:43 UTC

Achiziții, Fuziuni, Preluări

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ian. 2026, 22:42 UTC

Câștiguri

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ian. 2026, 22:41 UTC

Câștiguri

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ian. 2026, 22:41 UTC

Câștiguri

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ian. 2026, 22:40 UTC

Principalele dinamici ale pieței

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ian. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ian. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ian. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 ian. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ian. 2026, 21:22 UTC

Achiziții, Fuziuni, Preluări

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ian. 2026, 21:18 UTC

Achiziții, Fuziuni, Preluări

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ian. 2026, 21:05 UTC

Achiziții, Fuziuni, Preluări

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ian. 2026, 20:29 UTC

Achiziții, Fuziuni, Preluări

AbbVie Near Deal for Revolution Medicines -- Update

7 ian. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ian. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ian. 2026, 19:48 UTC

Principalele dinamici ale pieței

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat